Pandemic influenza pharmacovigilance updates

Between December 2009 and August 2010, the European Medicines Agency published regular updates on safety monitoring of vaccines and medicines used during the pandemic. The updates provided information on:

• the evolution of the A/H1N1 pandemic in the European Union (EU);
• an estimate of the number of doses of pandemic-influenza vaccines and antiviral medicines authorised by the Agency distributed or administered in the EU;
• a summary of the suspected adverse reactions reported to the Agency after use of pandemic-influenza vaccines and antiviral medicines;
• other information on the benefits and risks of pandemic-influenza vaccines and antiviral medicines.

The information in the updates was extracted from EudraVigilance, a database and management system managed by the Agency on behalf of Member States, for collecting and evaluating reports of suspected adverse reactions in the European Economic Area (EEA).

Reports were submitted to EudraVigilance by national medicines regulatory agencies and marketing authorisation holders. The updates also included some information on vaccine safety made available by Member States.

Date	Update number	Document reference
19/08/2010	22	EMA/527985/2010
22/07/2010	21	EMA/472001/2010
18/06/2010	20	EMA/395118/2010
03/06/2010	19	EMA/356087/2010
20/05/2010	18	EMA/326582/2010
05/05/2010	17	EMA/281958/2010
22/04/2010	16	EMA/255907/2010
08/04/2010	15	EMA/213238/2010
24/03/2010	14	EMA/150633/2010
10/03/2010	13	EMA/150633/2010
24/02/2010	12	EMA/117826/2010
17/02/2010	11	EMA/102392/2010
10/02/2010	10	EMA/86784/2010
03/02/2010	9	EMA/71116/2010
27/01/2010	8	EMA/55806/2010
20/01/2010	7	EMA/39205/2010
13/01/2010	6	EMA/21345/2010
06/01/2010	5	EMA/4476/2010
23/12/2009	4	EMA/841003/2009
16/12/2009	3	EMA/813036/2009
09/12/2009	2	EMA/790386/2009
03/12/2009	1	EMEA/784681/2009